EUVIMEDEUVIMED entdecken
Open Access

Development and validation of a multiparameter prognostic model for extranodal natural killer/T-cell lymphoma: Integration of clinical, pathological, and molecular biomarkers

Shishou Wu, Yifei Liu, Lei Jiang, Licai An, Yuanfeng Zhang, Yu Pan, Liling Song iD, Yunjun Wang, Guohua Yu

Cytojournal · 09.04.2026 · 23 · 24

DOI: 10.25259/cytojournal_34_2025 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cytojournal, online erschienen am 09.04.2026. Verfasst von Shishou Wu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Yantai Yuhuangding Hospital, Yantai, China. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

The objectives of the study are to develop and validate a novel prognostic model for extranodal natural killer/T-cell lymphoma (ENKTCL) by integrating clinical and pathological parameters. Material and Methods: We retrospectively analyzed 106 patients with ENKTCL (2008–2020) from the Department of Pathology of Yantai Yuhuangding Hospital and the Affiliated Hospital of Nantong University, constructing the novel international prognostic index (NIPI) model through multivariable Cox regression of immunohistochemistry (IHC) markers (age, MTP53, Ki-67, lactate dehydrogenase, hemoglobin, platelet-tolymphocyte ratio) and quantitative dot blot (QDB) tumor microenvironment features.

Results

The model demonstrated significant risk stratification ( P < 0.001) with a 3-year area under the curve of 0.72 (IHC) and 0.80 (QDB), outperforming Ann Arbor staging ( P > 0.05) and existing international prognostic index ( P = 0.00036)/natural killer lymphoma prognostic index ( P = 0.00017) models. The QDB-based implementation showed superior prognostic discrimination ( P = 0.00014), highlighting its potential for precise individualized therapy.

Conclusion

NIPI provides improved risk stratification for ENKTCL, and QDB-based analysis offers enhanced precision in individualized therapy. This model addresses the unmet needs for ENKTCL prognostication and warrants further multicenter validation.

Schlagwörter

Stichwörter der Autor:innen

Monoclonal antibody Ki-67Mutant P53NK/T-cell lymphomaPrognostic modelQuantitative dot blot

Autor:innen und Institutionen

  • Department of Pathology, Yantai Yuhuangding Hospital, Yantai, China.
  • Department of Pathology, Affiliated Hospital of Nantong University, Nantong, China.
  • Department of Hematology, Yantai Yuhuangding Hospital, Yantai, China.

ORCID-Profile: Liling Song

Zitieren

APA

Wu, S., Liu, Y., Jiang, L., An, L., Zhang, Y., Pan, Y., Song, L., Wang, Y., & Yu, G. (2026). Development and validation of a multiparameter prognostic model for extranodal natural killer/T-cell lymphoma: Integration of clinical, pathological, and molecular biomarkers. Cytojournal, 23, 24. https://doi.org/10.25259/cytojournal_34_2025

Vancouver

Wu S, Liu Y, Jiang L, An L, Zhang Y, Pan Y, et al. Development and validation of a multiparameter prognostic model for extranodal natural killer/T-cell lymphoma: Integration of clinical, pathological, and molecular biomarkers. Cytojournal. 2026;23:24. doi:10.25259/cytojournal_34_2025

BibTeX
@article{Wu2026,
  author = {Wu, Shishou and Liu, Yifei and Jiang, Lei and An, Licai and Zhang, Yuanfeng and Pan, Yu and Song, Liling and Wang, Yunjun and Yu, Guohua},
  title = {Development and validation of a multiparameter prognostic model for extranodal natural killer/T-cell lymphoma: Integration of clinical, pathological, and molecular biomarkers},
  journal = {Cytojournal},
  year = {2026},
  volume = {23},
  pages = {24},
  doi = {10.25259/cytojournal_34_2025}
}
Kostenlos starten →